Immediate Impact
76 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Bispecific antibodies: advancing precision oncology
2024 Standout
Works of Kees Bisschop being referenced
Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study
2017
Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Kees Bisschop | 118 | 34 | 38 | 48 | 40 | 7 | 175 | |
| Ravichandra Karra Gurunath | 120 | 52 | 74 | 72 | 23 | 10 | 251 | |
| Francesc Pons | 40 | 63 | 19 | 34 | 32 | 8 | 153 | |
| Daniel A. Wattson | 58 | 40 | 16 | 46 | 51 | 6 | 197 | |
| Shyamprasad Deraje Vasudeva | 71 | 20 | 19 | 142 | 65 | 8 | 224 | |
| L.B.J. van Iersel | 58 | 27 | 14 | 24 | 18 | 7 | 149 | |
| Nicholas Hearle | 81 | 32 | 23 | 48 | 12 | 7 | 174 | |
| Dawn Dolan | 126 | 21 | 58 | 32 | 30 | 7 | 194 | |
| Judith Sirokay | 78 | 18 | 47 | 64 | 20 | 9 | 152 | |
| Sierra Min Li | 52 | 43 | 45 | 159 | 42 | 7 | 295 | |
| M. Milder | 177 | 19 | 49 | 63 | 119 | 8 | 278 |
All Works
Login with ORCID to disown or claim papers
Loading papers...